在国家肺部查试验中,肺癌切除后的长期存活率
Alexandra L Potter1, Priyanka Senthil1, Alisha Keshwani1
1Division of Thoracic Surgery, Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts.
The Annals of thoracic surgery
|January 12, 2024
概括
这项研究发现,在IA阶段非小细胞肺癌 (NSCLC) 手术后的10年生存率是58%的带切除术. 肺癌仍然是这些患者的主要死亡原因.
科学领域:
- 胸部外科手术 胸部外科手术
- 在瘤学瘤学.
- 肺部医学 肺部医学
背景情况:
- 国家肺部查试验 (NLST) 提供了数据来评估早期肺癌的结果.
- 病理阶段IA非小细胞肺癌 (NSCLC) 代表了肺癌的早期阶段.
- 手术干预是可切除NSCLC的主要治疗方式.
研究的目的:
- 评估IA期NSCLC手术切除后的长期生存率.
- 确定治疗IA期NSCLC的患者死亡的主要原因.
- 根据不同的外科手术方法来比较生存结果,包括叶切除术,细分切除术和切除术.
主要方法:
- 在NLST数据库中对被诊断患有病态阶段IANSCLC的患者进行分析.
- 评估5年和10年整体存活率和肺癌特定存活率.
- 按手术程序类型分层对生存数据的分层 (分层切除术,分片切除术,切除术).
- 评估死亡原因和肺癌累积发病率的死亡率,特别是在空腔切除术后.
主要成果:
- 总共有380名患者被纳入调查,其中带切除术是最常见的手术 (86.6%).
- 10年整体存活率为58.3%的叶切除术,59.9%的细分切除术和45.2%的切除术.
- 肺癌10年特定存活率为74.3%的叶切除术,81.3%的细分切除术,84.8%的切除术.
- 肺癌是导致死亡的首要原因,占乳房切除术后死亡人数的55.8%,十年累计发病率为22.5%.
结论:
- 在NLST队列中,针对IA期NSCLC的叶片切除术后的10年整体存活率为58%.
- 肺癌仍然是接受早期NSCLC手术的患者死亡的主要原因.
- 虽然手术切除提供了生存益处,但对复发和二次恶性瘤的持续监测至关重要.
更多相关视频
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
290
05:39Author Spotlight: A Non-Intubated Video-Assisted Thoracoscopic Surgery with Multimodal Analgesia and Sevoflurane Inhalation Anesthesia
Published on: May 26, 2023
1.5K
相关概念视频
Cancer Survival Analysis
353
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
353
Pneumothorax-II
153
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
153
